{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:20:44Z","timestamp":1789071644304,"version":"build-2803163510"},"reference-count":17,"publisher":"Cardiofront, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.4022\/jafib.2119","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:23:10Z","timestamp":1558624990000},"source":"Crossref","is-referenced-by-count":3,"title":["Does Left Atrial Appendage Closure Reduce Mortality? A Vital Status Analysis of the Randomized PROTECT AF and PREVAIL Clinical Trials"],"prefix":"10.4022","volume":"11","author":[{"given":"William","family":"Whang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2440","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"key_R01","first-page":"1988","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.","volume-title":"JAMA.","volume":"312 (19)","year":"2014"},{"key":"key_R02","first-page":"1","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.","volume-title":"J. Am. Coll. Cardiol.","volume":"64 (1)","year":"2014"},{"key":"key_R03","first-page":"2614","article-title":"Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.","volume":"65 (24)","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R04","first-page":"2964","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.","volume":"70 (24)","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R05","first-page":"1492","article-title":"Calculating the number needed to treat for trials where the outcome is time to an event.","volume":"319 (7223)","year":"1999","journal-title":"BMJ."},{"key":"key_R06","first-page":"394","article-title":"Symptomatic Carotid Occlusion Is Frequently Associated With Microembolization.","volume":"48 (2)","year":"2017","journal-title":"Stroke."},{"key":"key_R07","first-page":"955","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383 (9921)","year":"2014","journal-title":"Lancet."},{"key":"key_R08","first-page":"1435","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure.","volume":"345 (20)","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key_R09","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.","volume":"346 ()","year":"2013","journal-title":"BMJ."},{"key":"key_R10","article-title":"AHRQ Technology Assessments Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death. Rockville (MD): Agency for Healthcare Research and Quality (US).","year":"2013"},{"key":"key_R11","first-page":"1539","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure.","volume":"352 (15)","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"key_R12","first-page":"1419","article-title":"Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.","volume":"12 (9)","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"key_R13","first-page":"857","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146 (12)","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"key_R14","first-page":"627","article-title":"Antiplatelet Therapy for Long-term Secondary Prevention After Myocardial Infarction.","volume":"1 (6)","year":"2016","journal-title":"JAMA Cardiol."},{"key":"key_R15","first-page":"417","article-title":"Catheter Ablation for Atrial Fibrillation with Heart Failure.","volume":"378 (5)","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"key_R16","first-page":"2485","article-title":"5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.","volume":"385 (9986)","year":"2015","journal-title":"Lancet."},{"key":"key_R17","first-page":"2451","article-title":"Temporal Changes in Subsequent Malignancies Among Childhood Cancer Survivors-Reply.","volume":"317 (23)","year":"2017","journal-title":"JAMA."}],"container-title":["Journal of Atrial Fibrillation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T07:47:15Z","timestamp":1558770435000},"score":1,"resource":{"primary":{"URL":"http:\/\/jafib.com\/published.php?type=full&id=2119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12,31]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.4022\/jafib.2119"],"URL":"https:\/\/doi.org\/10.4022\/jafib.2119","relation":{},"ISSN":["1941-6911"],"issn-type":[{"value":"1941-6911","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"article-number":"2119"}}